Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

力太 - NMPA Drug Approval Details

Approvals/NMPA/Alanyl Glutamine Injection

Approved

化学药品

Alanyl Glutamine Injection

Fresenius Kabi Austria Gmbh🇨🇳 National Medical Products Administration

Approval Date: Sep 29, 2024
Approval ID: 8dsiOpsw5iP
Company: Fresenius Kabi Austria Gmbh
Type: 化学药品

Approval Details

Approval Id: 8dsiOpsw5iP
Approval Number: 国药准字HJ20150560
Generic Name: 丙氨酰谷氨酰胺注射液
Generic Name En: Alanyl Glutamine Injection
Trade Name: 力太
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 100ml:20g
Reg Date: 2024-09-29
Expired Date: 2029-09-28
Company Name: Fresenius Kabi Austria Gmbh
Production Company Name: Fresenius Kabi Austria Gmbh
Company Detail Path: /organization/fresenius-kabi-austria-gmbh
Production Company Detail Path: /organization/fresenius-kabi-austria-gmbh

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 29, 2024

Approval ID

8dsiOpsw5iP

Type

化学药品

Back to NMPA Approvals